These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3582721)

  • 1. A post-marketing acceptability study in 11,685 patients of the efficacy of timolol/bendrofluazide in the management of hypertension in general practice.
    Marsh BT; Atkins MJ; Talbot DJ; Fairey IT
    J Int Med Res; 1987; 15(2):106-14. PubMed ID: 3582721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timolol/bendrofluazide combination ('Prestim') in the treatment of poorly controlled hypertensive patients in general practice.
    Douglas-Jones AP
    Pharmatherapeutica; 1984; 3(9):631-5. PubMed ID: 6728865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-centre, general practice assessment of a timolol/bendrofluazide combination ('Prestim') in the treatment of mild to moderate hypertension.
    Head AC
    Pharmatherapeutica; 1984; 3(10):650-6. PubMed ID: 6463065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of timolol/bendrofluazide (Prestim) in the treatment of hypertensive patients failing to respond to other antihypertensives.
    Ellis R; Wood SJ
    J Int Med Res; 1983; 11(6):359-63. PubMed ID: 6140195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of 500 patients with mild to moderate hypertension who had successfully completed a 3-month general practice study of a timolol-bendrofluazide combination ('Prestim').
    Head AC; Marsh BT; Fairey IT
    Curr Med Res Opin; 1987; 10(8):562-5. PubMed ID: 3315469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre general practice study on the use of a timolol/bendrofluazide combination ('Prestim') in the management of hypertension: preliminary report.
    Langrick AF; Head AC
    Curr Med Res Opin; 1981; 7(4):268-75. PubMed ID: 7226875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hospital out-patient study of timolol/bendrofluazide combination ('Prestim') in essential hypertension.
    Kubik MM
    Curr Med Res Opin; 1980; 7(1):47-54. PubMed ID: 7428413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prestim in the management of mild to moderate essential hypertension in general practice.
    Peacock K; Hodge B
    J Int Med Res; 1983; 11(3):186-9. PubMed ID: 6347751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timolol and bendrofluazide in the management of hypertension in general practice.
    Wheatley D
    Eur J Clin Pharmacol; 1978 Dec; 14(5):319-24. PubMed ID: 365544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management vf essential hypertension with once daily administration of timolol maleate and bendrofluazide.
    Deering RB; Fox AS; Ison LJ
    J Int Med Res; 1977; 5(2):114-9. PubMed ID: 326593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crossover comparison of a timolol/bendrofluazide combination and methyldopa in essential hypertension.
    Spira M
    Curr Med Res Opin; 1977; 5(3):252-7. PubMed ID: 162662
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term usage of Prestim (timolol/bendrofluazide) in the management of mild to moderate hypertension in general practice.
    Hosie J; Jones JC; Clifford PD
    Br J Clin Pract; 1983; 37(11-12):393-6. PubMed ID: 6367796
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of a fixed ratio combination of hydrochlorothiazide, amiloride and timolol ('Moducren') given once versus twice daily in mild to moderate hypertension.
    Young JH; VandenBurg MJ; Isitt VL; Currie WJ
    Pharmatherapeutica; 1984; 4(1):64-8. PubMed ID: 6504947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.
    Vanmolkot FH; de Hoon JN; van de Ven LL; Van Bortel LM
    J Hum Hypertens; 1999 Aug; 13(8):559-63. PubMed ID: 10455479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management.
    Parry EE; Arr S; Tait D
    Pharmatherapeutica; 1983; 3(5):294-9. PubMed ID: 6844366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with timolol maleate monotherapy of hypertension.
    Bannon JA; Stewart KA; DeLisser O; Schrogie JJ
    Arch Intern Med; 1986 Apr; 146(4):654-7. PubMed ID: 3963944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.
    Girvin B; Johnston GD
    J Hypertens; 1998 Jul; 16(7):1049-54. PubMed ID: 9794747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.
    Wilcox RG; Mitchell JR
    Br Med J; 1977 Aug; 2(6086):547-50. PubMed ID: 329948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil and bendrofluazide in the treatment of hypertension: a controlled study of effectiveness alone and in combination.
    Benjamin N; Phillips RJ; Robinson BF
    Eur J Clin Pharmacol; 1988; 34(3):249-53. PubMed ID: 3294021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.